Showing results (71-80 of 374) with videos related to
Sort By:
Pageof 38
Biochemistry|August 30, 1994
Inactivation of subtilisin Carlsberg by N-((tert-butoxycarbonyl)alanylprolylphenylalanyl)-O-benzoylhydroxyl- amine: formation of a covalent enzyme-inhibitor linkage in the form of a carbamate derivativeA C Steinmetz, H U Demuth, D RingeProceedings of the National Academy of Sciences of the United States of America|October 19, 2001
THEMATICS: a simple computational predictor of enzyme function from structureM J Ondrechen, J G Clifton, D RingeProtein Engineering|December 1, 1987
The 3.0 A crystal structure of xylose isomerase from Streptomyces olivochromogenesG K Farber, G A Petsko, D RingeBiochemistry|March 17, 1999
Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemaseA A Morollo, G A Petsko, D RingeDeutsche Medizinische Wochenschrift (1946)|November 27, 1981
[Treatment of Paget's disease of bone with salmon calcitonin (author's transl)]F Kuhlencordt, J D Ringe, H P KruseDeutsche Medizinische Wochenschrift (1946)|February 10, 1978
[Results of long-term treatment of primary osteoporosis with sodium fluoride (author's transl)]H P Kruse, F Kuhlencordt, J D RingeMechanisms of Ageing and Development|January 1, 1985
Increasing skeletal involution in the elderly?J D Ringe, W Rehpenning, E Steinhagen-ThiessenBiotechnology and Bioengineering|September 1, 1992
Computer-assisted modeling of subtilisin enantioselectivity in organic solventsP A Fitzpatrick, D Ringe, A M KlibanovBiochemistry|February 11, 1997
Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9-A resolutionJ P Shaw, G A Petsko, D RingeArzneimittel-Forschung|March 25, 2011
Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosisJohann D Ringe, Erich Schacht, Laurent Dukas, et al.Pageof 38